Evotec SE EVO
NASDAQ EVO
$1.67 +0.05 (+3.09%)
At close: Sep 17, 2026 · 4:00 PM EDT

Evotec SE (EVO) Net Margin Growth (3y) (2022 - 2025)

Analysis

Evotec SE (EVO) Net Margin Growth (3y) (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -237.00
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 391.00
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -273.00
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -923.00
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -619.00
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -1,663.00
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 1,763.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -8.45 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -982,444.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.66 Mn
Sep 30, 2025 -5,332.00
Jun 30, 2025 0.00
Mar 31, 2025 4.45 Mn
Dec 31, 2024 -3.59 Mn
Sep 30, 2024 -8.41 Mn
Jun 30, 2024 -4.34 Mn
Mar 31, 2024 -3.96 Mn
Dec 31, 2023 -550,246.00
Dec 31, 2022 531,648.00